Chengjia Li

Chengjia Li

Auto-generated profile, based on publicly available information

Chengjia Li

Heilongjiang University of Chinese Medicine, 24 Heping Road, Xiangfang District, Harbin 150040, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Molecular Omics
Verified
Journal Article
Closed access
PDF file
ZLZhiping Liu
Zhiping Liu
HWHe Wang
He Wang
CLChengjia Li
Chengjia Li
JYJianfei Yang
Jianfei Yang
QSQiushi Suo
Qiushi Suo
RQRui Qie
Rui Qie
The ethyl acetate extract of Caesalpinia sappan L. is a traditional Chinese medicine extract commonly used in the treatment of atherosclerosis. However, the mechanism of its use in the treatment of AS is not yet clear, which seriously affects the wide-scale application of this drug. In this study, a combination of metabolomics and lipidomics was used to analyze cardiac tissue to obtain differential metabolites and differential lipid molecules, bioinformatic analysis was performed on the significantly different metabolites and subclass analysis, cluster analysis, and chain length and chain saturation analyses were performed on screened lipid molecules showing significant differences. A correlation network diagram of the screened differential metabolites and differential lipid molecules was constructed. Hematoxylin and eosin staining of thoracic aorta in rats confirmed its therapeutic effect. This study found that the ethyl acetate extract of C. sappan L. upregulates D-mannose through the lysosome pathway, enhances lysosomal function, mediates autophagy, and indirectly regulates the levels of lipid subtypes such as lysophosphatidylinositol and phosphatidylserine, thereby improving AS.

1 January 2025 in Cardiology Research and Practice
Verified
Journal Article
Open access
YSYuming Shao
Yuming Shao
YLYang Li
Yang Li
BWBing Wang
Bing Wang
CLChengjia Li
Chengjia Li
HCHuijun Chen
Huijun Chen
Electroacupuncture (EA) therapy combines electrical stimulation with traditional acupuncture therapy and is widely used as a physical therapy in various fields. Coronary heart disease (CHD) is a prevalent cardiovascular condition. Applying EA in the treatment of CHD patients has proven to effectively enhance therapeutic outcomes and improve prognosis. This paper summarizes the potential mechanisms of EA in the treatment of CHD, its therapeutic effects on CHD patients, and analyzes the current bottlenecks in the application of EA therapy for CHD. Furthermore, it discusses potential future directions for EA in CHD management.